Tumors screening package for women - for early detection of tumors and monitoring general health.

What the package includes:

Alpha-Fetoprotein (AFP):
- Used to detect liver tumors and sometimes ovarian cancers.
- Elevated levels may indicate problems or abnormal liver development.

CA 15.3 (Breast Cancer Marker):
- Used for monitoring and diagnosing breast cancer.
- Helps in assessing disease progression or response to treatment.

Carcinoembryonic Antigen (CEA):
- Indicator for detecting cancers in the colon, rectum, lung, or ovary.
- Also used to monitor therapeutic progress for certain types of cancer.

CA 19.9 (Gastrointestinal Tumor Marker):
- Used to detect cancer in the pancreas, liver, and gallbladder.
- Helps in monitoring the progression of gastrointestinal cancer.

CA 125 (Ovarian Cancer Marker):
- Used for diagnosing and monitoring ovarian cancer cases.
- May also rise in some non-cancerous conditions such as endometriosis.

What does this package provide?

- Early detection of common cancers in women.
- Tracking treatment progress if cancer has been previously diagnosed.
- Reassurance for women with a family history of cancerous tumors.
- Providing a comprehensive overview of the health of organs related to various biomarkers.

Who is this package suitable for?

- Women with a family history of tumors.
- Those experiencing symptoms like unexplained bloating, unexplained weight loss, or persistent fatigue.
- Women who wish to undergo routine screening for early detection of tumors.
- Women undergoing follow-up after a previous cancer diagnosis to monitor their health condition.